A.M. Vali
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
Papers in
-
- Nanoparticle-Based Drug Delivery 6
-
- Cancer therapeutics and mechanisms 3
- Co-authors
- Simin Dadashzadeh (9 shared papers)Azadeh Haeri (2 shared papers)Seyed Nasser Ostad (1 shared paper)Bijan Shafaghi (1 shared paper)Anna Kelsey (1 shared paper)Michael A. Clarke (1 shared paper)Farzad Kobarfard (1 shared paper)Fariba Johari Daha (1 shared paper)
- Journals
- International Journal of Pharmaceutics (2 papers)Nuclear Medicine and Biology (1 paper)Research in Pharmaceutical Sciences (1 paper)Journal of Pharmaceutical and Biomedical Analysis (1 paper)Journal of Pharmacy & Pharmaceutical Sciences (1 paper)
- Partner nations
- IranUnited Kingdom
In The Last Decade
A.M. Vali
10 papers receiving 384 citations
Peers
Comparison fields: 5 of 70
- Biomaterials 165
- Pharmaceutical Science 55
- Analytical Chemistry 32
- Oncology 59
- Pharmacology 37
Countries citing papers authored by A.M. Vali
This map shows the geographic impact of A.M. Vali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Vali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Vali more than expected).
Fields of papers citing papers by A.M. Vali
This network shows the impact of papers produced by A.M. Vali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Vali. The network helps show where A.M. Vali may publish in the future.
Co-authors
The 8 scholars most cited alongside A.M. Vali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 102 | |
| 2 | 2009 | 68 | |
| 3 | 2007 | 55 | |
| 4 | 2012 | 49 | |
| 5 | 2002 | 43 | |
| 6 | 2008 | 26 | |
| 7 | 2005 | 23 | |
| 8 | 2008 | 16 | |
| 9 | 1993 | 12 | |
| 10 | Preparation and characterization of valspodar loaded nanoliposomes as a potential adjuvant therapy for drug-resistant tumors | 2012 | 1 |
About A.M. Vali
A.M. Vali is a scholar working on Biomaterials, Molecular Biology, Oncology, Surgery and Pharmacology, having authored 10 papers that have together received 395 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Cancer therapeutics and mechanisms (3 papers), Intraperitoneal and Appendiceal Malignancies (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Lung Cancer Research Studies (1 paper), Epilepsy research and treatment (1 paper) and Fetal and Pediatric Neurological Disorders (1 paper). The work is most often cited by research in Biomaterials (165 citations), Pharmaceutical Science (55 citations), Analytical Chemistry (32 citations), Oncology (59 citations) and Pharmacology (37 citations). A.M. Vali has collaborated with scholars based in Iran and United Kingdom. Frequent co-authors include Simin Dadashzadeh, Azadeh Haeri, Seyed Nasser Ostad, Bijan Shafaghi, Anna Kelsey, Michael A. Clarke, Farzad Kobarfard and Fariba Johari Daha. Their work appears in journals such as International Journal of Pharmaceutics, Nuclear Medicine and Biology, Research in Pharmaceutical Sciences, Journal of Pharmaceutical and Biomedical Analysis and Journal of Pharmacy & Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.